20.67500 EUR
0.235
1.12%
Last update Dec 18, 8:04 AM CET
Main market
Day range
20.67500
20.67500
Previous close
20.91000
Open
20.67500
Access this stock data via API
Subscribe
Apellis Pharmaceuticals Inc.
20.68
0.24
1.12%

Financials

Income statement

Fundamentals currency is USD
Fiscal date Sep 2025 Jun 2025 Mar 2025 Dec 2024
Total reported revenue 391.2M 152.3M 142.3M 181.3M
Cost of revenue 20.9M 11.6M 29.3M 34.8M
Gross profit 370.2M 140.6M 113.0M 146.4M
Operating expense
Research & development 58.2M 57.2M 73.7M 65.1M
Selling general and admin 121.7M 111.9M 110.3M 103.6M
Other operating expenses
Operating income 190.4M -28.4M -71.1M -22.3M
Non operating interest income
Income 3.7M 2.2M 2.3M 2.9M
Expense 9.6M 9.5M 9.4M 9.8M
Other income expense 31.6K 124.5K -140.7K -1.5M
Pretax income 184.5M -35.6M -78.4M -30.8M
Tax provision 513.5K 397.5K 290.9K 244.0K
Net income 184.0M -36.0M -78.7M -31.0M
Basic EPS -0.3 -0.7
Diluted EPS -0.3 -0.7
Basic average shares 107.5M 107.0M
Diluted average shares 107.5M 107.0M
EBITDA 194.4M -25.7M -68.6M -20.5M
Net income from continuing op. 184.0M -36.0M -78.7M -31.0M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 3 hours 41 minutes

18:18
00:00
08:00
22:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 22:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).